Indicated for: malaria
Route of administration: oral
Substance: artemether + lumefantrine (antimalarials)
ATC: P01BE52 (Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, plain)
Artemether+lumefantrine is a combination medication used in the treatment of uncomplicated malaria caused by Plasmodium falciparum. Artemether is a derivative of artemisinin that acts rapidly against the parasite, while lumefantrine provides a longer-lasting effect, preventing recurrence of the infection.
This combination is administered orally, usually in tablet form, and is recommended as a first-line therapy in many malaria-endemic regions. The treatment is effective in clearing the parasite from the blood and rapidly alleviating symptoms such as fever, chills, and fatigue.
Common side effects include nausea, headache, dizziness, and insomnia. In rare cases, allergic reactions or cardiac disturbances may occur, requiring careful monitoring.
Artemether+lumefantrine is an essential therapeutic option in the fight against malaria, helping to reduce the mortality and morbidity associated with this disease.